Dodel R - Search Results

1

Evaluation of health-care utilization among adult patients with epilepsy in Germany.

Strzelczyk A, Nickolay T, Bauer S, Haag A, Knake S, Oertel WH, Reif PS, Rosenow F, Reese JP, Dodel R, Hamer HM. Strzelczyk A, et al. Among authors: dodel r. Epilepsy Behav. 2012 Apr;23(4):451-7. doi: 10.1016/j.yebeh.2012.01.021. Epub 2012 Mar 3. Epilepsy Behav. 2012. PMID: 22381385

2

International guide to drugs for Parkinson's disease.

Oertel WH, Dodel RC. Oertel WH, et al. Among authors: dodel rc. Mov Disord. 1995 Mar;10(2):121-31. doi: 10.1002/mds.870100202. Mov Disord. 1995. PMID: 7753054

3

[Costs of drug treatment of neurologic diseases: Parkinson disease, dystonia, epilepsy].

Dodel RC, Pepperl S, Köhne-Volland R, Szucs T, Werhahn KJ, Noachtar S, Oertel WH. Dodel RC, et al. Med Klin (Munich). 1996 Jul 15;91(7):479-85. Med Klin (Munich). 1996. PMID: 8756119 Review. German.

4

Pallidal lesions. Structural and functional magnetic resonance imaging.

Bucher SF, Seelos KC, Dodel RC, Paulus W, Reiser M, Oertel WH. Bucher SF, et al. Among authors: dodel rc. Arch Neurol. 1996 Jul;53(7):682-6. doi: 10.1001/archneur.1996.00550070124020. Arch Neurol. 1996. PMID: 8929177

5

Activation mapping in essential tremor with functional magnetic resonance imaging.

Bucher SF, Seelos KC, Dodel RC, Reiser M, Oertel WH. Bucher SF, et al. Among authors: dodel rc. Ann Neurol. 1997 Jan;41(1):32-40. doi: 10.1002/ana.410410108. Ann Neurol. 1997. PMID: 9005863

6

[Cost of illness in Parkinson disease. A retrospective 3-month analysis of direct costs].

Dodel RC, Singer M, Köhne-Volland R, Selzer R, Scholz W, Rathay B, Oertel WH. Dodel RC, et al. Nervenarzt. 1997 Dec;68(12):978-84. doi: 10.1007/s001150050226. Nervenarzt. 1997. PMID: 9465341 German.

7

Costs of drug treatment in Parkinson's disease.

Dodel RC, Eggert KM, Singer MS, Eichhorn TE, Pogarell O, Oertel WH. Dodel RC, et al. Mov Disord. 1998 Mar;13(2):249-54. doi: 10.1002/mds.870130209. Mov Disord. 1998. PMID: 9539337

8

Costs of treating dystonias and hemifacial spasm with botulinum toxin A.

Dodel RC, Kirchner A, Koehne-Volland R, Künig G, Ceballos-Baumann A, Naumann M, Brashear A, Richter HP, Szucs TD, Oertel WH. Dodel RC, et al. Pharmacoeconomics. 1997 Dec;12(6):695-706. doi: 10.2165/00019053-199712060-00009. Pharmacoeconomics. 1997. PMID: 10175981

9

The economic impact of Parkinson's disease. An estimation based on a 3-month prospective analysis.

Dodel RC, Singer M, Köhne-Volland R, Szucs T, Rathay B, Scholz E, Oertel WH. Dodel RC, et al. Pharmacoeconomics. 1998 Sep;14(3):299-312. doi: 10.2165/00019053-199814030-00006. Pharmacoeconomics. 1998. PMID: 10186468

10

A polymorphism in the intronic region of the IL-1alpha gene and the risk for Parkinson's disease.

Dodel RC, Lohmüller F, Du Y, Eastwood B, Gocke P, Oertel WH, Gasser T. Dodel RC, et al. Neurology. 2001 Apr 10;56(7):982-3. doi: 10.1212/wnl.56.7.982. Neurology. 2001. PMID: 11294947 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

341 results

Search Page